Literature DB >> 25973098

Polymorphisms in the DUSP10 gene are associated with sex-specific colorectal cancer risk in a Han population.

Xianglong Duan1, Ya Gao2, Hua Yang3, Tian Feng4, Tianbo Jin5, Yanbin Long6, Chao Chen5.   

Abstract

AIMS AND
BACKGROUND: Colorectal cancer (CRC) is common, especially in developed countries. CRC is a multifactorial disease influenced by both environmental and genetic factors. In this study, we investigated the role of genetic polymorphisms in the dual specificity protein phosphatase 10 (DUSP10) gene especially in sex-specific.
METHODS: We selected nine DUSP10 tag single nucleotide polymorphisms (tSNPs) previously reported to be associated with colorectal cancer risk of in a case-control study from Xi'an city of China.
RESULTS: In females, three SNPs were associated with decreased CRC risk: rs11118838, rs12724393, and rs908858. However, in males, only one SNP, rs908858, was associated with decreased CRC risk. Using a log-additive model, the rs11118838 "C" allele and the rs12724393 "G" allele were associated with decreased CRC risk in females, while the rs908858 "G" allele was associated with decreased CRC risk in both females and males. In addition, haplotype analysis also found "CG" and "CCT" were associated with the decreased CRC risk in females.
CONCLUSIONS: Our findings suggest that DUSP10 polymorphisms influence the risk of developing CRC in Han Chinese and emphasize that sex should be considered in the design and analysis of health studies and biomedical research.

Entities:  

Keywords:  Colorectal cancer; DUSP10; case-control study; tag single nucleotide polymorphism (tSNP)

Mesh:

Substances:

Year:  2015        PMID: 25973098      PMCID: PMC4396290     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

Review 1.  Statistics notes. The odds ratio.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  2000-05-27

2.  [EXAMPLE OF THE USE OF THE NONPARAMETRIC TEST. TEST X2 FOR COMPARISON OF 2 INDEPENDENT EXAMPLES].

Authors:  C ADAMEC
Journal:  Cesk Zdrav       Date:  1964-12

3.  Reaction mechanism determines NMDA receptor response to repetitive stimulation.

Authors:  Gabriela Popescu; Antoine Robert; James R Howe; Anthony Auerbach
Journal:  Nature       Date:  2004-08-12       Impact factor: 49.962

4.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

5.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci.

Authors:  Yong Yong Shi; Lin He
Journal:  Cell Res       Date:  2005-02       Impact factor: 25.617

6.  Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5.

Authors:  T Tanoue; T Moriguchi; E Nishida
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

7.  Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1.

Authors:  S C Kim; J S Hahn; Y H Min; N C Yoo; Y W Ko; W J Lee
Journal:  Blood       Date:  1999-06-01       Impact factor: 22.113

8.  Novel function of MKP-5/DUSP10, a phosphatase of stress-activated kinases, on ERK-dependent gene expression, and upregulation of its gene expression in colon carcinomas.

Authors:  Miyuki Nomura; Ken-Ichi Shiiba; Chiaki Katagiri; Isao Kasugai; Kouhei Masuda; Ikuro Sato; Masayuki Sato; Yoichiro Kakugawa; Eiki Nomura; Katsuhisa Hayashi; Yoshihiro Nakamura; Toshiyuki Nagata; Tsunayuki Otsuka; Ryuichi Katakura; Yoji Yamashita; Masami Sato; Nobuhiro Tanuma; Hiroshi Shima
Journal:  Oncol Rep       Date:  2012-06-12       Impact factor: 3.906

9.  cDNA microarray analysis reveals an overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia.

Authors:  Orlev Levy-Nissenbaum; Orit Sagi-Assif; Pia Raanani; Abraham Avigdor; Isaac Ben-Bassat; Isaac P Witz
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

10.  Comparison of risk factors for colon and rectal cancer.

Authors:  Esther K Wei; Edward Giovannucci; Kana Wu; Bernard Rosner; Charles S Fuchs; Walter C Willett; Graham A Colditz
Journal:  Int J Cancer       Date:  2004-01-20       Impact factor: 7.396

View more
  3 in total

1.  Genetic analysis of pharmacogenomic VIP variants in the Blang population from Yunnan Province of China.

Authors:  Chan Zhang; Weiwei Guo; Yujing Cheng; Qi Li; Xin Yang; Run Dai; Linhao Zhu; Wanlu Chen
Journal:  Mol Genet Genomic Med       Date:  2019-04-05       Impact factor: 2.183

Review 2.  Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer.

Authors:  Alicia M Hidalgo-Estévez; Konstantinos Stamatakis; Marta Jiménez-Martínez; Ricardo López-Pérez; Manuel Fresno
Journal:  Front Pharmacol       Date:  2020-04-29       Impact factor: 5.810

3.  Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population.

Authors:  Iker Alegria-Lertxundi; Carmelo Aguirre; Luis Bujanda; Francisco Javier Fernández; Francisco Polo; José M Ordovás; M Carmen Etxezarraga; Iñaki Zabalza; Mikel Larzabal; Isabel Portillo; Marian M de Pancorbo; Leire Palencia-Madrid; Ana M Rocandio; Marta Arroyo-Izaga
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.